Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases
暂无分享,去创建一个
Shuzhen Guo | Sihua Gao | Jianzhao Niu | Min Fu | Shuzhen Guo | Dongwei Zhang | J. Niu | Yu Li | Dongwei Zhang | Lili Wang | Rufeng Ma | Chenyue Liu | Haixia Liu | Ruyuan Zhu | Minke Tang | Min Fu | Haixia Liu | R. Zhu | Rufeng Ma | Yu Li | Sihua Gao | Chenyue Liu | Minke Tang | Lili Wang
[1] A. Tuttolomondo,et al. Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine. , 2016, Current pharmaceutical design.
[2] A. Villablanca,et al. Lipotoxic brain microvascular injury is mediated by activating transcription factor 3-dependent inflammatory and oxidative stress pathways , 2016, Journal of Lipid Research.
[3] R. V. Vander Heide,et al. Pathobiology of Ischemic Heart Disease: Past, Present and Future. , 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[4] Xiuping Chen,et al. Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-κB pathways , 2016, Cell adhesion & migration.
[5] S. Parthasarathy,et al. Atherosclerosis--do we know enough already to prevent it? , 2016, Current opinion in pharmacology.
[6] A. Clarke,et al. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease. , 2015, The Cochrane database of systematic reviews.
[7] Dongwei Zhang,et al. Herba Epimedii: An Ancient Chinese Herbal Medicine in the Prevention and Treatment of Osteoporosis. , 2015, Current pharmaceutical design.
[8] A. D'Ascola,et al. Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease , 2015, Stem cells international.
[9] L. Boon,et al. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[10] J. Saffitz. Pathobiology of Cardiovascular Diseases: Past, Present and Future Perspectives (CVP 25th Anniversary Special Review Article) The electrical heart: 25 years of discovery in cardiac electrophysiology, arrhythmias and sudden death , 2016 .
[11] Suowen Xu,et al. Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E‐deficient mice: role of lectin‐like oxidized LDL receptor‐1 (LOX‐1) , 2015, British journal of pharmacology.
[12] Wei Li,et al. Danshen improves damaged cardiac angiogenesis and cardiac function induced by myocardial infarction by modulating HIF1α/VEGFA signaling pathway. , 2015, International journal of clinical and experimental medicine.
[13] Yingzi Zhao,et al. Vascular nitric oxide: Beyond eNOS. , 2015, Journal of pharmacological sciences.
[14] Yuhong Li,et al. Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling. , 2015, International journal of clinical and experimental medicine.
[15] Baoman Li,et al. Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion , 2015, ASN neuro.
[16] G. Semenza,et al. Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs. , 2015, Cardiovascular research.
[17] Pau-Chung Chen,et al. Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study , 2015, BMC Complementary and Alternative Medicine.
[18] Ping Li,et al. Screening of direct thrombin inhibitors from Radix Salviae Miltiorrhizae by a peak fractionation approach. , 2015, Journal of pharmaceutical and biomedical analysis.
[19] D. Lackland,et al. Global burden of cardiovascular disease and stroke: hypertension at the core. , 2015, The Canadian journal of cardiology.
[20] Xian-xie Zhang,et al. Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor. , 2015, Journal of ethnopharmacology.
[21] K. Rahman,et al. Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology. , 2015, Chinese journal of natural medicines.
[22] Jing Luo,et al. Compound Danshen (Salvia miltiorrhiza) dripping pill for coronary heart disease: an overview of systematic reviews. , 2015, The American journal of Chinese medicine.
[23] Lianhe Zheng,et al. Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents , 2015, Respiratory Physiology & Neurobiology.
[24] H. Chunyan,et al. Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats. , 2014, Journal of ethnopharmacology.
[25] Sihua Gao,et al. Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs. , 2014, Journal of ethnopharmacology.
[26] A. Sinusas,et al. Clinical feasibility study to detect angiogenesis following bone marrow stem cell transplantation in chronic ischaemic heart failure. , 2014, Nuclear medicine communications.
[27] Y. Huang,et al. Effectiveness of combination therapy of atorvastatin and non lipid-modifying tanshinone IIA from Danshen in a mouse model of atherosclerosis. , 2014, International journal of cardiology.
[28] Yuyan Zhang,et al. Lipid-lowering effects of Danhong injection on hyperlipidemia rats. , 2014, Journal of ethnopharmacology.
[29] P. Leung,et al. A randomized placebo controlled trial of an innovative herbal formula in the prevention of atherosclerosis in postmenopausal women with borderline hypercholesterolemia. , 2014, Complementary therapies in medicine.
[30] M. M. Rahman,et al. Conversion of salvianolic acid B into salvianolic acid A in tissues of Radix Salviae Miltiorrhizae using high temperature, high pressure and high humidity. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[31] A. Sinusas,et al. Clinical feasibility study to detect angiogenesis following bone marrow stem cell transplantation in chronic ischaemic heart failure , 2014, Nuclear medicine communications.
[32] W. Su,et al. Chinese medicinal formula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme , 2014, Biotechnology, biotechnological equipment.
[33] K. Bernstein,et al. Renal angiotensin-converting enzyme and blood pressure control , 2014, Current opinion in nephrology and hypertension.
[34] Chun Meng,et al. Protection of salvianolate against atherosclerosis via regulating the inflammation in rats , 2014, Journal of Huazhong University of Science and Technology [Medical Sciences].
[35] D. Sosnowska,et al. Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice. , 2013, American journal of physiology. Heart and circulatory physiology.
[36] Lan Huang,et al. Beneficial effects of a polysaccharide from Salvia miltiorrhiza on myocardial ischemia-reperfusion injury in rats. , 2013, Carbohydrate polymers.
[37] B. Baban,et al. Mechanisms of load dependency of myocardial ischemia reperfusion injury. , 2013, American journal of cardiovascular disease.
[38] S. Tyagi,et al. Matrix metalloproteinase inhibition mitigates renovascular remodeling in salt-sensitive hypertension , 2013, Physiological reports.
[39] J. Eikelboom,et al. Targeting the unstable plaque in acute coronary syndromes. , 2013, Clinical therapeutics.
[40] N. Zhong,et al. Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats. , 2013, American journal of respiratory cell and molecular biology.
[41] P. Potter,et al. Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen"). , 2013, Journal of natural products.
[42] Xibao Liu,et al. Contribution and regulation of TRPC channels in store-operated Ca2+ entry. , 2013, Current topics in membranes.
[43] Ying Chen,et al. Tanshinone IIA Attenuates H₂O₂ -induced injury in human umbilical vein endothelial cells. , 2012, The American journal of Chinese medicine.
[44] L. Dai,et al. Effect of Salvia miltiorrhiza Hydrophilic Extract on the Endothelial Biomarkers in Diabetic Patients with Chronic Artery Disease , 2012, Phytotherapy research : PTR.
[45] Y. Kwan,et al. Involvements of calcium channel and potassium channel in Danshen and Gegen decoction induced vasodilation in porcine coronary LAD artery. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[46] Wen-Yu Wu,et al. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components , 2012, Acta Pharmacologica Sinica.
[47] Bao-yan Liu,et al. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine. , 2012, Journal of ethnopharmacology.
[48] T. Minamino. Cardioprotection From Ischemia/Reperfusion Injury , 2012 .
[49] Weidong Zhang,et al. Metabolomic profiles of myocardial ischemia under treatment with salvianolic acid B , 2012, Chinese Medicine.
[50] P. Komesaroff,et al. Cell adhesion molecules as pharmaceutical target in atherosclerosis. , 2012, Mini reviews in medicinal chemistry.
[51] Jun-Rong Du,et al. Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction. , 2012, Journal of ethnopharmacology.
[52] S. Tsai,et al. Tanshinone IIA attenuates cyclic strain‐induced endothelin‐1 expression in human umbilical vein endothelial cells , 2012, Clinical and experimental pharmacology & physiology.
[53] Q. Qian,et al. Effect of Salvia miltiorrhiza Hydrophilic Extract on Antioxidant Enzymes in Diabetic Patients with Chronic Heart Disease: A Randomized Controlled Trial , 2012, Phytotherapy research : PTR.
[54] Cai-xia Li. Antithrombotic study of Danhong Injection in the treatment of old patient with unstable angina pectoris , 2012 .
[55] Chun-Lin Chen,et al. Cardiovascular protection with danshensu in spontaneously hypertensive rats. , 2011, Biological & pharmaceutical bulletin.
[56] Ping Wu,et al. Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[57] Z. Zuo,et al. Acute treatment with Danshen-Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKCɛ/mK(ATP) pathway in rats. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[58] J. Ho,et al. Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection , 2011, Journal of Biomedical Science.
[59] Beibei Han,et al. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. , 2011, Archives of cardiovascular diseases.
[60] Z. Zuo,et al. Myocardial post-conditioning with Danshen-Gegen decoction protects against isoproterenol-induced myocardial injury via a PKCε/mKATP-mediated pathway in rats , 2011, Chinese medicine.
[61] Y. Bobryshev,et al. Current advances in understanding of immunopathology of atherosclerosis , 2011, Virchows Archiv.
[62] Ping Wang,et al. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[63] Da-zhu Li,et al. CD4+CD25+Foxp3+ Regulatory T Cells Protect the Proinflammatory Activation of Human Umbilical Vein Endothelial Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[64] N. Tentolouris,et al. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies , 2010, Vascular health and risk management.
[65] Jin Han,et al. Pathophysiology of voltage-gated K+ channels in vascular smooth muscle cells: modulation by protein kinases. , 2010, Progress in biophysics and molecular biology.
[66] Joseph A. Hill,et al. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. , 2010, The American journal of cardiology.
[67] K. Gatter,et al. Hypoxia and activated VEGF/receptor pathway in multiple myeloma. , 2010, Anticancer research.
[68] Bin-Nan Wu,et al. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel. , 2010, Life sciences.
[69] O. Halevy,et al. Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: effect on myotube fusion. , 2010, Experimental cell research.
[70] Y. Tong,et al. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[71] S. Leung,et al. Effects of the aqueous extract of Salvia Miltiorrhiza (danshen) and its magnesium tanshinoate B‐enriched form on blood pressure , 2009, Phytotherapy research : PTR.
[72] C. China Pharmacopoeia,et al. Pharmacopoeia of the People's Republic of China , 2010 .
[73] Y. M. Kim,et al. Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. , 2009, European journal of pharmacology.
[74] Zheng-Tao Wang,et al. Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen). , 2009, Journal of chromatography. A.
[75] M. Büchler,et al. Danshen protects kidney grafts from ischemia/reperfusion injury after experimental transplantation , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[76] Tian Tian,et al. [Effects of Salviae miltiorrhizae and salvianolic acid B on microcirculation of liver in mice with portal hypertension]. , 2009, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.
[77] Yan Zhu,et al. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS , 2009, The Journal of Steroid Biochemistry and Molecular Biology.
[78] W. Zhiguo. The Observation on the Therapeutic Effect of Shenfu Injection in the Treatment of 129 Cases of Chronic Heart Failure , 2009 .
[79] Z. Valenta,et al. Proinflammatory status, genetics and atherosclerosis. , 2009, Physiological research.
[80] Minhui Li,et al. Investigation of Danshen and related medicinal plants in China. , 2008, Journal of ethnopharmacology.
[81] S. Leung,et al. Vascular effects of different lipophilic components of "Danshen", a traditional Chinese medicine, in the isolated porcine coronary artery. , 2008, Journal of natural products.
[82] S. Ogawa,et al. Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[83] C. Lam,et al. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. , 2008, Immunobiology.
[84] H. Nishimatsu,et al. Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species. , 2008, American journal of physiology. Heart and circulatory physiology.
[85] Chulhee Choi,et al. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury. , 2008, European journal of pharmacology.
[86] Young-Chae Chang,et al. Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP‐9 activity through AKT signaling pathway , 2008, Journal of cellular biochemistry.
[87] E. Liong,et al. Chronic hypoxia upregulates the expression and function of proinflammatory cytokines in the rat carotid body , 2008, Histochemistry and Cell Biology.
[88] T. Hibi,et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. , 2008, Pharmacology & therapeutics.
[89] Hui Zhang,et al. Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit. , 2008, Journal of ethnopharmacology.
[90] J. Raffetto,et al. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. , 2008, Biochemical pharmacology.
[91] Z. Zuo,et al. Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[92] Yingjin Yuan,et al. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[93] Hong Wang,et al. Investigation of the effect of tanshinone IIA on nitric oxide production in human vascular endothelial cells by fluorescence imaging. , 2007, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[94] P. Ferdinandy,et al. Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning , 2007, Pharmacological Reviews.
[95] T. Cheng. Cardiovascular effects of Danshen. , 2007, International journal of cardiology.
[96] R. Poręba,et al. Chemokines and left ventricular function in patients with acute myocardial infarction. , 2007, European journal of internal medicine.
[97] Zhi Zheng,et al. Effect of salvia miltiorrhiza Bge on left ventricular hypertrophy and the expression of tumor necrosis factor-α in spontaneously hypertensive rats , 2007 .
[98] Ying Xia,et al. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. , 2007, Inflammation & allergy drug targets.
[99] K. Lee,et al. New developments in the chemistry and biology of the bioactive constituents of tanshen , 2007, Medicinal research reviews.
[100] Zhi Zheng,et al. Effect of salvia miltiorrhiza Bge on left ventricular hypertrophy and the expression of tumor necrosis factor-alpha in spontaneously hypertensive rats. , 2007, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[101] Weirong Wang,et al. Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. , 2006, Journal of ethnopharmacology.
[102] Jianghao Sun,et al. Characterization of tanshinones in the roots of Salvia miltiorrhiza (Dan-shen) by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.
[103] W. Ho,et al. Dimethyl Lithospermate B, an Extract of Danshen, Suppresses Arrhythmogenesis Associated With the Brugada Syndrome , 2006, Circulation.
[104] G. Wang,et al. Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis. , 2005, Medical science monitor : international medical journal of experimental and clinical research.
[105] Su Lian-sheng. The influence of salvianolic acid B and tanshinoneIIA on the nitric oxide and triglyceride in sera of atherosclerosis rabbits , 2006 .
[106] Zhong Zuo,et al. Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use , 2005, Journal of clinical pharmacology.
[107] Yingjin Yuan,et al. Aqueous extract of Salvia miltiorrhiza attenuates increased endothelial permeability induced by tumor necrosis factor-alpha. , 2005, International immunopharmacology.
[108] L. Shimoda,et al. Chronic hypoxia inhibits Kv channel gene expression in rat distal pulmonary artery. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[109] Hong Wang,et al. Tanshinone: an inhibitor of proliferation of vascular smooth muscle cells. , 2005, Journal of ethnopharmacology.
[110] C. Chan,et al. Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction. , 2004, Life sciences.
[111] De-guo Wang,et al. Endoxin Antagonist Lessens Myocardial Ischemia Reperfusion Injury , 2004, Cardiovascular Drugs and Therapy.
[112] Danny L Wang,et al. Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells. , 2004, Molecular pharmacology.
[113] L. Navar,et al. The intrarenal renin-angiotensin system in hypertension. , 2004, Kidney international.
[114] H. Oh,et al. Inhibition of angiotensin converting enzyme by lithospermic acid B isolated from radix Salviae miltiorrhiza Bunge , 2003, Phytotherapy research : PTR.
[115] K. Tanonaka,et al. Effects of tanshinone VI on the hypertrophy of cardiac myocytes and fibrosis of cardiac fibroblasts of neonatal rats. , 2002, Planta medica.
[116] Z. Galis,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[117] L. Foo,et al. Polyphenolics of Salvia--a review. , 2002, Phytochemistry.
[118] J. Azuma,et al. Protective effect of Salvia miltiorrhiza on angiotensin II-induced hypertrophic responses in neonatal rat cardiac cells. , 2001, Japanese journal of pharmacology.
[119] S. Mccune,et al. Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats. , 1999, The American journal of physiology.
[120] S. Mccune,et al. Myocardial tumor necrosis factor-α secretion in hypertensive and heart failure-prone rats. , 1999, American journal of physiology. Heart and circulatory physiology.
[121] M. Shiao,et al. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[122] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[123] A. Motulsky,et al. Genetics and Atherosclerosis , 1974 .
[124] G. Schramm. [Pharmacopeia of the People's Republic of China, 1953 edition]. , 1955, Pharmazeutische Zentralhalle fur Deutschland.
[125] J. Hewitt,et al. The role of lipids and lipoproteins in atherosclerosis. , 1950, Science.